![Detlef F. Albrecht](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Detlef F. Albrecht
Directeur Technique/Scientifique/R&D chez
SATSUMA PHARMACEUTICALS, INC.
Profil
Detlef F.
Albrecht was the founder of Relypsa, Inc. founded in 2007, where he held the title of Chief Medical Officer & SVP-Research & Development.
Currently, he is the Chief Medical Officer at Satsuma Pharmaceuticals, Inc. since 2017.
Dr. Albrecht's former positions include President, Chief Executive Officer & Director at Sorbent Therapeutics, Inc., Senior Director-Clinical Development at Miravant Medical Technologies, Director-Clinical Development at Schwarz Pharma, Inc., Vice President-Clinical Development at ALZA Corp., Chief Medical Officer & Senior Vice President at IntraBiotics Pharmaceuticals, Inc., Chief Medical Officer, SVP-Research & Development at Ilypsa, Inc., and Chief Medical Officer & Head-Drug Development at Armetheon, Inc. Dr. Albrecht holds a doctorate degree from RWTH Aachen University.
Postes actifs de Detlef F. Albrecht
| Sociétés | Poste | Début |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2017 |
Anciens postes connus de Detlef F. Albrecht
| Sociétés | Poste | Fin |
|---|---|---|
Armetheon, Inc.
 Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Directeur Technique/Scientifique/R&D | 01/06/2017 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Directeur Technique/Scientifique/R&D | 02/01/2009 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Directeur Technique/Scientifique/R&D | 22/01/2007 |
| ALZA CORPORATION | Corporate Officer/Principal | 01/01/2004 |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Corporate Officer/Principal | 01/01/1999 |
Formation de Detlef F. Albrecht
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Miravant Medical Technologies
 Miravant Medical Technologies Pharmaceuticals: MajorHealth Technology Develops light activated drugs and associated devices for photodynamic therapy | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Health Technology |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cardiovascular focused late-clinical stage specialty pharmaceutical company | Health Technology |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company for migraine and debilitating conditions | Health Technology |
Choisissez Zonebourse 
